Education
About Us
Working with TipRanks
Follow Us
Leila Alland Insider Profile
4 Followers
Leila Alland, CMO at PMV Pharmaceuticals, holds 173.61K shares in Abeona Therapeutics (Ticker: ABEO), holds 45.91K shares in PMV Pharmaceuticals (Ticker: PMVP). Most recently, Leila Alland Sold ― shares of Abeona Therapeutics on Feb 02, 2026 for an estimated value of $91.95K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+30.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Leila Alland holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 18, 2023 - Sep 18, 2024
Return:+75.60%
The most profitable trade made by Leila Alland
Leila Alland's Trading History
PMV Pharmaceuticals
Sep 18, 2023
CMO
Informative Sell
41.65K
$71.62K
Abeona Therapeutics
Feb 02, 2026
Director
Informative Sell
91.95K
$826.40K
List of latest transactions for each holding click on a transaction to see Leila Alland's performance on stock
You May Also Like
Leila Alland insider profile FAQ
What is the percentage of profitable transactions made by Leila Alland?
The percentage of profitable transactions made by Leila Alland is 75%.
What is the average return per transaction made by Leila Alland?
The average return per transaction made by Leila Alland is 30.00%.
What stocks does Leila Alland hold?
Leila Alland holds: PMVP, ABEO stocks.
What was Leila Alland’s latest transaction?
Leila Alland latest transaction was an Informative Sell of $91.95K.
What was Leila Alland's most profitable transaction?
Leila Alland’s most profitable transaction was an Informative Sell of PMVP stock on September 18, 2023. The return on the trade was 75.60%.
What is Leila Alland's role in PMV Pharmaceuticals?
Leila Alland's role in PMV Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.